The DOJ has Entered the Gene Patent Fight

Last Friday, the Department of Justice (DOJ) submitted an amicus curiae brief in the Association for Molecular Pathology v. United States Patent and Trademark Office case (the “Myriad genes case”), which is currently before the Federal Circuit.  Commentators,...